1α,25-dihydroxycholecalciferol reduces rejection and improves survival in rat liver allografts

Hepatology

Volumn 34, Issue 5, 2001, Pages

  Redaelli, Claudio A ^a   Wagner, Markus ^a   Tien, Ying Hua ^a   Mazzucchelli, Luca ^a   Stahel, Philip F ^a   Schilling, Martin K ^a   Dufour, Jean François ^a  

^a UNIVERSITY OF BERN   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARTATE AMINOTRANSFERASE; BILIRUBIN; CALCITRIOL; CALCIUM; CYCLOSPORIN A; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 2; INTERLEUKIN 4; LACTATE DEHYDROGENASE;

ALLOGRAFT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; CALCIUM INTAKE; CONTROLLED STUDY; DRUG EFFECT; DRUG RESPONSE; GRAFT REJECTION; GRAFT SURVIVAL; IMMUNOSUPPRESSIVE TREATMENT; LACTATE DEHYDROGENASE BLOOD LEVEL; LIVER TRANSPLANTATION; MALE; NONHUMAN; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RAT;

EID: 0034767279     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1053/jhep.2001.28705     Document Type: Article

References (43)

1. Expression of 1,25-dihydroxyvitamin D(3) receptor in the immune system
2. 3-binding macromolecules in human B lymphocytes: Effects on immunoglobulin production
3. 1,25-Dihydroxyvitamin D3 receptors in human leukocytes
4. 3 regulates proliferation of activated T-lymphocyte subsets
5. 3: A novel immunoregulatory hormone
6. 3 (calcitriol)
7. 3-mediated effects
8. 3 (calcitriol) induces apoptosis in stimulated T cells through an IL-2 dependent mechanism
9. 3
10. 3 inhibits gamma-interferon synthesis by normal human peripheral blood lymphocytes
11. 3. Specific inhibition at the level of messenger RNA
12. 3-regulated expression of genes involved in human T-lymphocyte proliferation and differentiation
13. 3 on human lymphocytes and monocyte/macrophages: Inhibition of interleukin-2 and augmentation of interleukin-1 production
14. 3 suppresses human T helper/inducer lymphocyte activity in vitro
15. Inhibition of Th1 development and treatment of chronicrelapsing experimental allergic encephalomyelitis by a non-hypercalcemic analogue of 1,25-dihydroxyvitamin D(3)
16. 3
17. 3 inhibits differentiation, maturation, activation, and survival of dendritic cells leading to impaired alloreactive T cell activation
18. 3. Involvement of NF-kappaB downregulation in transcriptional repression of the p40 gene
19. 3: Preferential inhibition of Thl functions
20. 3 prolongs graft survival without compromising host resistance to infection or bone mineral density
21. 3 reversibly blocks the progression of relapsing encephalomyelitis, a model of multiple sclerosis
22. 3 on the induction of experimental autoimmune thyroiditis
23. 1,25-Dihydroxycholecalciferol inhibits the progression of arthritis in murine models of human arthritis
24. 3
25. 3
26. 3 as dose-reducing agents for classical immunosuppressants
27. 3 analog and cyclosporine
28. The effects of combined treatment with the novel vitamin D analogue MC 1288 and cyclosporine A on cardiac allograft survival
29. A surgical experience with five hundred thirty liver transplants in the rat
30. Banff schema for grading liver allograft rejection: An international consensus document
31. The effect of cyclosporin on endothelin levels after orthotopic liver transplantation in rats
32. MC 1288 - A vitamin D analogue with immunosuppressive effects on heart and small bowel grafts
33. A vitamin D analog, MC1288, inhibits adventitial inflammation and suppresses intimal lesions in rat aortic allografts
34. 3 analogue 1,25-dihydroxy -delta 16-cholecalciferol
35. Two novel vitamin D analogues, KH 1060 and CB 966, prolong skin allograft survival in mice
36. Prevention of murine experimental allergic encephalomyelitis: Cooperative effects of cyclosporine and 1 alpha, 25-(OH)2D3
37. IL-10 immunosuppression in transplantation
38. 3
39. 3-a hormone with immunomodulaory properties